NipahVR: a resource of multi-targeted putative therapeutics and epitopes for the Nipah virus.


Journal

Database : the journal of biological databases and curation
ISSN: 1758-0463
Titre abrégé: Database (Oxford)
Pays: England
ID NLM: 101517697

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 01 08 2019
revised: 20 12 2019
accepted: 23 12 2020
entrez: 25 2 2020
pubmed: 25 2 2020
medline: 20 11 2020
Statut: ppublish

Résumé

Nipah virus (NiV) is an emerging and priority pathogen from the Paramyxoviridae family with a high fatality rate. It causes various diseases such as respiratory ailments and encephalitis and poses a great threat to humans and livestock. Despite various efforts, there is no approved antiviral treatment available. Therefore, to expedite and assist the research, we have developed an integrative resource NipahVR (http://bioinfo.imtech.res.in/manojk/nipahvr/) for the multi-targeted putative therapeutics and epitopes for NiV. It is structured into different sections, i.e. genomes, codon usage, phylogenomics, molecular diagnostic primers, therapeutics (siRNAs, sgRNAs, miRNAs) and vaccine epitopes (B-cell, CTL, MHC-I and -II binders). Most decisively, potentially efficient therapeutic regimens targeting different NiV proteins and genes were anticipated and projected. We hope this computational resource would be helpful in developing combating strategies against this deadly pathogen. Database URL: http://bioinfo.imtech.res.in/manojk/nipahvr/.

Identifiants

pubmed: 32090261
pii: 5743493
doi: 10.1093/database/baz159
pmc: PMC7036594
pii:
doi:

Substances chimiques

Antiviral Agents 0
Epitopes 0
RNA, Untranslated 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press.

Références

Antiviral Res. 2017 Aug;144:147-152
pubmed: 28629988
J Infect Dis. 2019 May 24;219(12):1867-1878
pubmed: 30364984
Virology. 2000 Jun 5;271(2):334-49
pubmed: 10860887
Virology. 2002 Apr 25;296(1):190-200
pubmed: 12036330
Antiviral Res. 2013 Oct;100(1):38-43
pubmed: 23911335
Nat Commun. 2012 Apr 24;3:796
pubmed: 22531181
Sci Rep. 2016 Sep 16;6:32713
pubmed: 27633273
Lancet. 1999 Oct 9;354(9186):1257-9
pubmed: 10520635
Proc Natl Acad Sci U S A. 2015 May 12;112(19):6164-9
pubmed: 25918406
Vaccine. 2016 Jun 24;34(30):3525-34
pubmed: 27154393
NPJ Vaccines. 2017 Aug 8;2:21
pubmed: 29263876
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29643201
Nucleic Acids Res. 2012 Jan;40(Database issue):D593-8
pubmed: 22006842
Asia Pac J Public Health. 2015 Mar;27(2):NP824-32
pubmed: 23343646
Curr Drug Metab. 2018;19(3):236-263
pubmed: 29380697
Genome Biol. 2005;6(3):R28
pubmed: 15774029
Methods Enzymol. 2007;427:3-23
pubmed: 17720476
Virus Res. 2011 Dec;162(1-2):173-83
pubmed: 21963678
Asian Pac J Trop Med. 2017 Jun;10(6):529-538
pubmed: 28756915
J Tradit Complement Med. 2014 Jan;4(1):24-35
pubmed: 24872930
Antiviral Res. 2008 Dec;80(3):324-31
pubmed: 18687361
Nat Biotechnol. 2014 Apr;32(4):347-55
pubmed: 24584096
Ann Neurol. 2001 Jun;49(6):810-3
pubmed: 11409437
Antiviral Res. 2013 Oct;100(1):8-13
pubmed: 23838047
Bioinformatics. 2001 Dec;17(12):1236-7
pubmed: 11751237
Nature. 2005 Jul 21;436(7049):401-5
pubmed: 16007075
J Transl Med. 2013 Dec 11;11:305
pubmed: 24330765
Emerg Infect Dis. 2006 Feb;12(2):235-40
pubmed: 16494748
Emerg Infect Dis. 2006 Dec;12(12):1888-94
pubmed: 17326940
Emerg Infect Dis. 2011 May;17(5):907-9
pubmed: 21529409
Emerg Infect Dis. 2005 Jul;11(7):1042-7
pubmed: 16022778
Adv Bioinformatics. 2014;2014:402492
pubmed: 25147564
PLoS One. 2010 Aug 06;5(8):e11843
pubmed: 20700506
Am J Trop Med Hyg. 2012 Sep;87(3):576-8
pubmed: 22802440
J Cell Biochem. 2019 May;120(5):7082-7095
pubmed: 30417438
Indian J Med Res. 2006 Apr;123(4):553-60
pubmed: 16783047
Rev Med Virol. 2019 Jan;29(1):e2010
pubmed: 30251294
Sci Transl Med. 2014 Jun 25;6(242):242ra82
pubmed: 24964990
Emerg Infect Dis. 2005 Dec;11(12):1949-51
pubmed: 16485487
J Virol. 2006 Dec;80(24):12293-302
pubmed: 17005664
Vaccine. 2016 Jun 3;34(26):2971-2975
pubmed: 26973068
Bioinformatics. 2003 May 22;19(8):1009-14
pubmed: 12761064
Antimicrob Agents Chemother. 2006 May;50(5):1768-72
pubmed: 16641448
Clin Infect Dis. 2009 Dec 1;49(11):1743-8
pubmed: 19886791
Front Pharmacol. 2019 Feb 12;10:71
pubmed: 30809147
Vaccine. 2014 May 7;32(22):2637-44
pubmed: 24631094
J Infect Public Health. 2019 Sep - Oct;12(5):634-639
pubmed: 30808593
Science. 2000 May 26;288(5470):1432-5
pubmed: 10827955
Emerg Infect Dis. 2019 May;25(5):1003-1006
pubmed: 31002049
Sci Rep. 2018 May 15;8(1):7604
pubmed: 29765101
Vaccine. 2004 Aug 13;22(23-24):3195-204
pubmed: 15297074
PLoS One. 2013 May 07;8(5):e62216
pubmed: 23667458
Nucleic Acids Res. 2013 Jan;41(Database issue):D579-83
pubmed: 23193299
PLoS One. 2011;6(8):e23443
pubmed: 21853133
Emerg Infect Dis. 2008 Aug;14(8):1309-11
pubmed: 18680665
Bioinformatics. 2015 May 1;31(9):1472-4
pubmed: 25524896
Sci Rep. 2016 Feb 10;6:20678
pubmed: 26861761
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Sci Rep. 2016 Sep 01;6:30870
pubmed: 27581337
Emerg Infect Dis. 2007 Jul;13(7):1031-7
pubmed: 18214175
J Med Virol. 2016 Mar;88(3):380-8
pubmed: 26252523
J Med Chem. 2009 Jul 23;52(14):4257-65
pubmed: 19499921
Microbes Infect. 2001 Apr;3(4):279-87
pubmed: 11334745
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10652-7
pubmed: 15998730

Auteurs

Amit Kumar Gupta (AK)

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.

Archit Kumar (A)

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.

Akanksha Rajput (A)

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.

Karambir Kaur (K)

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.

Showkat Ahmed Dar (SA)

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.

Anamika Thakur (A)

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.

Kirti Megha (K)

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.

Manoj Kumar (M)

Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH